Terms: = Head and neck cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Clinical Outcome
13 results:
1. MicroRNA Gene Signature for Predicting Mechanisms in Nasopharyngeal Carcinoma: A Case Study on the Potential Application of Circulating Biomarkers.
Wardana T; Oktriani R; Murjayanto CH; Putri DU; Anwar SL; Aryandono T; Haryana SM
Microrna; 2023; 12(1):29-44. PubMed ID: 36121076
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of radiologic extranodal extension in patients with hypopharyngeal cancer treated with primary chemoradiation.
Fan KH; Yeh CH; Hung SP; Kang CJ; Huang SF; Chang KP; Wang HM; Chia-Hsun Hsieh J; Lin CY; Cheng AJ; Ng SH; Tung-Chieh Chang J
Radiother Oncol; 2021 Mar; 156():217-222. PubMed ID: 33385465
[TBL] [Abstract] [Full Text] [Related]
3. Immune related proteins and tumor infiltrating CD8+ lymphocytes in hypopharyngeal cancer in relation to human papillomavirus (HPV) and clinical outcome.
Landin D; Ährlund-Richter A; Mirzaie L; Mints M; Näsman A; Kolev A; Marklund L; Dalianis T; Munck-Wikland E; Ramqvist T
Head Neck; 2020 Nov; 42(11):3206-3217. PubMed ID: 32613643
[TBL] [Abstract] [Full Text] [Related]
4. Genetic Variations of
Psoma E; Koliou GA; Dimitrakopoulos FI; Papadopoulou K; Rontogianni D; Bobos M; Visvikis A; Kosmidis PA; Fountzilas G; Constantinidis J; Kalogera-Fountzila A
Anticancer Res; 2020 Feb; 40(2):677-688. PubMed ID: 32014908
[TBL] [Abstract] [Full Text] [Related]
5. Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma in Children and Adolescents: A Matched Cohort Analysis.
Li Y; Tang LQ; Liu LT; Guo SS; Liang YJ; Sun XS; Tang QN; Bei JX; Tan J; Chen S; Ma J; Zhao C; Chen QY; Mai HQ
Cancer Res Treat; 2018 Oct; 50(4):1304-1315. PubMed ID: 29334605
[TBL] [Abstract] [Full Text] [Related]
6. Genetic landscape of papillary thyroid carcinoma in the Chinese population.
Liang J; Cai W; Feng D; Teng H; Mao F; Jiang Y; Hu S; Li X; Zhang Y; Liu B; Sun ZS
J Pathol; 2018 Feb; 244(2):215-226. PubMed ID: 29144541
[TBL] [Abstract] [Full Text] [Related]
7. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract] [Full Text] [Related]
8. Combined oridonin with cetuximab treatment shows synergistic anticancer effects on laryngeal squamous cell carcinoma: involvement of inhibition of EGFR and activation of reactive oxygen species-mediated JNK pathway.
Cao S; Xia M; Mao Y; Zhang Q; Donkor PO; Qiu F; Kang N
Int J Oncol; 2016 Nov; 49(5):2075-2087. PubMed ID: 27667173
[TBL] [Abstract] [Full Text] [Related]
9. fas ligand (fasL, apo-1L/cd95L) expression and clinical outcome in papillary microcarcinoma and papillary thyroid carcinomas with diameter smaller than 1.5 centimeters.
Bayraktaroglu T; Boztepe H; Kapran Y; Tanakol R; Alagöl F
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):537-43. PubMed ID: 20013612
[TBL] [Abstract] [Full Text] [Related]
10. Influence of apoptosis (BCL2, fas), cell cycle (CCND1) and growth factor (EGF, EGFR) genetic polymorphisms on survival outcome: an exploratory study in squamous cell esophageal cancer.
Jain M; Kumar S; Upadhyay R; Lal P; Tiwari A; Ghoshal UC; Mittal B
Cancer Biol Ther; 2007 Oct; 6(10):1553-8. PubMed ID: 17912028
[TBL] [Abstract] [Full Text] [Related]
11. Reliability of platelet-derived endothelial cell growth factor as a prognostic factor for oral and oropharyngeal carcinomas.
Tsuzuki H; Sunaga H; Ito T; Narita N; Sugimoto C; Fujieda S
Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1071-8. PubMed ID: 16365220
[TBL] [Abstract] [Full Text] [Related]
12. High prevalence of c-RET expression in papillary thyroid carcinomas from the Korean population.
Lee S; Hong SW; Moon WC; Oh MR; Lee JK; Ahn CW; Cha BS; Kim KR; Lee HC; Lim SK
Thyroid; 2005 Mar; 15(3):259-66. PubMed ID: 15785245
[TBL] [Abstract] [Full Text] [Related]
13. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
Tang X; Wu W; Sun SY; Wistuba II; Hong WK; Mao L
Mol Cancer Res; 2004 Dec; 2(12):685-91. PubMed ID: 15634757
[TBL] [Abstract] [Full Text] [Related]
